Advertisement
Screener

GENZYME CORP Payments to Acquire Equity Method Investments

GENZYME CORP Payments to Acquire Equity Method Investments

GENZYME CORP reported Payments to Acquire Equity Method Investments of $3.63 million for the 12-month period ending 2010-12-31, per its 10-K filed 2011-03-01.

Discontinued › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquireEquityMethodInvestments · last filed 2011-03-01

  • GENZYME CORP payments to acquire equity method investments for the quarter ending 2010-12-31 was $718.00K.
  • GENZYME CORP payments to acquire equity method investments for the quarter ending 2010-09-30 was $1.45M.
  • GENZYME CORP payments to acquire equity method investments for the quarter ending 2010-06-30 was $0.00.
  • GENZYME CORP payments to acquire equity method investments for the quarter ending 2010-03-31 was $1.47M.
  • GENZYME CORP payments to acquire equity method investments for fiscal 2010 was $3.63M.
  • GENZYME CORP payments to acquire equity method investments for fiscal 2008 was $4.84M.
Period endPayments to Acquire Equity Method Investments 3 monthPayments to Acquire Equity Method Investments 6 monthPayments to Acquire Equity Method Investments 9 monthPayments to Acquire Equity Method Investments 12 month
2010-12-31$718.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01
$2.17M
derived: sum of 2 quarters · filed 2011-03-01
$2.17M
derived: sum of 3 quarters · filed 2011-03-01
$3.63M
10-K · filed 2011-03-01
2010-09-30$1.45M
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-11-09
$1.45M
derived: sum of 2 quarters · filed 2010-11-09
$2.92M
10-Q · filed 2010-11-09
2010-06-30$0.00
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2010-09-07
$1.47M
10-Q/A · filed 2010-09-07
2010-03-31$1.47M
10-Q/A · filed 2010-05-11
2008-12-31$4.84M
10-K · filed 2011-03-01